PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $20,433,000 | -45.1% | 455,276 | -68.3% | 0.09% | -44.1% |
Q1 2021 | $37,197,000 | +28.5% | 1,436,192 | 0.0% | 0.16% | +47.7% |
Q4 2020 | $28,954,000 | -7.2% | 1,436,192 | -10.0% | 0.11% | -12.8% |
Q3 2020 | $31,206,000 | -7.6% | 1,596,198 | -16.5% | 0.12% | -16.1% |
Q2 2020 | $33,756,000 | +184.7% | 1,911,446 | +13.8% | 0.15% | +104.1% |
Q1 2020 | $11,855,000 | +43.2% | 1,679,164 | +43.0% | 0.07% | +65.9% |
Q4 2019 | $8,279,000 | -41.3% | 1,174,282 | 0.0% | 0.04% | -54.2% |
Q3 2019 | $14,103,000 | +17.0% | 1,174,282 | +18.0% | 0.10% | +17.1% |
Q2 2019 | $12,050,000 | +137.3% | 995,082 | +146.4% | 0.08% | +156.2% |
Q1 2019 | $5,077,000 | – | 403,893 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $40,852,372 | 15.05% |
Kynam Capital Management, LP | 1,818,657 | $30,335,199 | 4.96% |
BVF INC/IL | 5,744,848 | $95,824,065 | 2.58% |
Ghost Tree Capital, LLC | 400,000 | $6,672,000 | 2.19% |
COWEN AND COMPANY, LLC | 1,657,551 | $27,647,950 | 1.93% |
RTW INVESTMENTS, LP | 5,415,514 | $90,330,774 | 1.91% |
Sio Capital Management, LLC | 248,127 | $4,138,758 | 1.28% |
683 Capital Management, LLC | 732,784 | $12,222,837 | 0.95% |
Artia Global Partners LP | 112,340 | $1,873,831 | 0.78% |
Perceptive Advisors | 1,054,273 | $17,585,274 | 0.59% |